Document is current
Any future updates will be listed below
-
Authors
Riou, Julien
Althaus, Christian L.
Allen, Hester
Cole, Michelle J.
Grad, Yonatan H.
Heijne, Janneke C. M.
Unemo, Magnus
Low, Nicola
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (199498)
Foundation for Innovative New Diagnostics
- License Information
-
More Information
Article History
Received: 22 November 2022
Accepted: 27 March 2023
First Online: 20 April 2023
Declarations
:
: No specific consent is required from participants because GRASP is routine public health surveillance and UK Health Security Agency has permission to handle data obtained by under Sect. 251 of the UK National Health Service Act of 2006, which was renewed annually by the ethics and confidentiality committee of the National Information Governance Board until 2013. Since 2013, UK Health Security Agency has had the power of approval of public health surveillance activity under Regulation 3 of the Health Service (Control of Patient Information) Regulations 2002. Anonymised data was used for this specific study. All methods were carried out in accordance with relevant guidelines and regulations. The original statement was used in a recent study using the same data ().
: Not applicable.
: NL is a member of the advisory board of Sefunda AG, a diagnostics company, which develops rapid tests for sexually transmitted infections, including detection of antimicrobial resistance. All the other authors do not possess any competing interests.
